Micrima has developed a radiowave based system for medical imaging with the first application being used to screen for breast cancer.
The Micrima MARIA system is based on technology originating from Bristol University. Radiowaves systems have significant advantages over existing X-ray technology being inherently safer, more mobile and less expensive to produce. In addition, radiowaves can be used on wider population groups, particularly younger women. The MARIA system has performed impressively in clinical trials and product launch is scheduled for 2015.
TVP invested in Micrima at the spinout stage and has supported subsequent funding rounds. Co-investors include Swarraton Partners, the British Business Bank Angel Co-fund.